"Serum Amyloid A Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ACUTE PHASE REACTION protein present in low concentrations in normal sera, but found at higher concentrations in sera of older persons and in patients with AMYLOIDOSIS. It is the circulating precusor of amyloid A protein, which is found deposited in AA type AMYLOID FIBRILS.
| Descriptor ID |
D000685
|
| MeSH Number(s) |
D12.776.049.407.750 D12.776.124.050.725
|
| Concept/Terms |
Serum Amyloid A Protein- Serum Amyloid A Protein
- Amyloid A Protein-Related Serum Component
- Amyloid A Protein Related Serum Component
- Amyloid Protein AA Precursor
- Serum Amyloid Protein A
- Amyloid Serum Protein SAA
- Amyloid-Related Serum Protein (SAA)
- Serum A Related Protein
- Serum Amyloid A
- Amyloid A Precursor
- Amyloid Protein SAA
|
Below are MeSH descriptors whose meaning is more general than "Serum Amyloid A Protein".
Below are MeSH descriptors whose meaning is more specific than "Serum Amyloid A Protein".
This graph shows the total number of publications written about "Serum Amyloid A Protein" by people in this website by year, and whether "Serum Amyloid A Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 2 | 4 | 6 |
| 2018 | 3 | 3 | 6 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 5 | 7 |
| 2021 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Serum Amyloid A Protein" by people in Profiles.
-
Hypothesis: AA amyloidosis is a factor causing systemic complications after coronavirus disease. Prion. 2021 12; 15(1):53-55.
-
Presence of a SARS-CoV-2 Protein Enhances Amyloid Formation of Serum Amyloid A. J Phys Chem B. 2021 08 19; 125(32):9155-9167.
-
Association between serum amyloid A levels and predicting disase severity in COVID-19 patients: a systematic review and meta-analysis. Eur Rev Med Pharmacol Sci. 2021 07; 25(13):4627-4638.
-
Prognostic accuracy of MALDI-TOF mass spectrometric analysis of plasma in COVID-19. Life Sci Alliance. 2021 08; 4(8).
-
Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis. Int J Infect Dis. 2021 Apr; 105:668-674.
-
Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis. Int Immunopharmacol. 2021 Jun; 95:107512.
-
Clinical characteristics of coronavirus disease 2019 (COVID-19) in patients out of Wuhan from China: a case control study. BMC Infect Dis. 2021 Feb 24; 21(1):207.
-
Serum Amyloid A in Inflammatory Rheumatic Diseases: A Compendious Review of a Renowned Biomarker. Front Immunol. 2020; 11:631299.
-
Altered high-density lipoprotein composition and functions during severe COVID-19. Sci Rep. 2021 01 27; 11(1):2291.
-
Interferon-?-induced protein 10 (IP-10) and serum amyloid A (SAA) are excellent biomarkers for the prediction of COVID-19 progression and severity. Life Sci. 2021 Mar 15; 269:119019.